2.16
Grace Therapeutics Inc-Aktien (GRCE) Preisverlauf
Täglich
Wöchentlich
Monatlich
7T
30T
60T
YTD
1J
| Datum | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-08-14 | $2.19 | $2.02 | $0.17 | 397,770.0 | +4.35% |
| 2026-08-13 | $2.13 | $2.06 | $0.072 | 190,330.0 | -1.43% |
| 2026-08-12 | $2.13 | $2.06 | $0.07 | 121,835.0 | -0.94% |
| 2026-08-11 | $2.13 | $2.08 | $0.05 | 97,763.0 | +0.47% |
| 2026-08-10 | $2.16 | $2.08 | $0.085 | 184,320.0 | -0.94% |
| 2026-08-07 | $2.16 | $2.10 | $0.0638 | 120,375.0 | +0.47% |
| 2026-08-06 | $2.25 | $2.08 | $0.17 | 162,686.0 | -0.93% |
| 2026-08-05 | $2.23 | $2.08 | $0.145 | 649,117.0 | -1.83% |
| 2026-08-04 | $2.18 | $2.07 | $0.11 | 100,067.0 | +4.81% |
| 2026-08-03 | $2.14 | $2.08 | $0.06 | 96,022.0 | +0.00% |
| 2026-07-31 | $2.17 | $2.03 | $0.1402 | 177,499.0 | +0.48% |
| 2026-07-30 | $2.08 | $1.95 | $0.13 | 296,802.0 | -0.48% |
| 2026-07-29 | $2.25 | $1.85 | $0.40 | 1,349,129.0 | -7.56% |
| 2026-07-28 | $2.38 | $2.14 | $0.24 | 517,933.0 | -2.17% |
| 2026-07-27 | $2.44 | $2.28 | $0.1599 | 116,092.0 | -1.29% |
| 2026-07-24 | $2.36 | $2.29 | $0.07 | 127,088.0 | -0.85% |
| 2026-07-23 | $2.39 | $2.35 | $0.0497 | 101,209.0 | -0.84% |
| 2026-07-22 | $2.43 | $2.36 | $0.07 | 103,719.0 | -2.47% |
| 2026-07-21 | $2.48 | $2.41 | $0.065 | 94,307.0 | +0.00% |
| 2026-07-20 | $2.48 | $2.39 | $0.09 | 104,821.0 | -1.62% |
| 2026-07-17 | $2.48 | $2.33 | $0.145 | 122,539.0 | +2.49% |
| 2026-07-16 | $2.50 | $2.33 | $0.165 | 279,698.0 | -0.82% |
Grace Therapeutics Inc-Aktien (GRCE) Preisverlauf Jahr für Jahr
In dieser detaillierten Analyse präsentieren wir einen umfassenden Überblick über die Kursbewegungen der Grace Therapeutics Inc-Aktie im Laufe der Jahre. Durch die Untersuchung der Jahresdaten können Investoren wertvolle Einblicke in die historische Performance und Volatilität der GRCE-Aktien gewinnen. Von bedeutenden Meilensteinen und Schwankungen bis hin zu bemerkenswerten Trends bietet diese gründliche Untersuchung der Preisgeschichte der Grace Therapeutics Inc-Aktie eine Grundlage für das Verständnis der Entwicklung der Aktien des Unternehmens im Laufe der Zeit.
Grace Therapeutics Inc-Aktien (GRCE) Preisverlauf 2026
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-08 | $2.25 | $2.02 | $0.23 | 2,518,055.0 | +3.85% |
| 2026-07 | $2.58 | $1.85 | $0.73 | 5,172,472.0 | -8.37% |
| 2026-06 | $2.71 | $2.08 | $0.6318 | 6,368,646.0 | -11.67% |
| 2026-05 | $2.60 | $2.08 | $0.52 | 7,971,138.0 | +14.73% |
| 2026-04 | $5.18 | $1.79 | $3.39 | 29,994,466.0 | -51.62% |
| 2026-03 | $4.94 | $3.58 | $1.36 | 10,979,184.0 | +7.93% |
| 2026-02 | $4.30 | $3.45 | $0.85 | 2,275,507.0 | +18.18% |
| 2026-01 | $3.94 | $3.40 | $0.538 | 2,461,431.0 | +4.91% |
Grace Therapeutics Inc-Aktien (GRCE) Preisverlauf 2025
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-12 | $3.67 | $3.08 | $0.5927 | 1,234,525.0 | +5.97% |
| 2025-11 | $3.29 | $2.95 | $0.34 | 1,077,562.0 | +0.79% |
| 2025-10 | $3.40 | $2.95 | $0.45 | 1,665,912.0 | +5.98% |
| 2025-09 | $3.34 | $2.91 | $0.43 | 1,718,096.0 | -1.75% |
| 2025-08 | $3.40 | $2.80 | $0.60 | 2,016,356.0 | +4.84% |
| 2025-07 | $3.74 | $2.86 | $0.8773 | 1,404,908.0 | -2.69% |
| 2025-06 | $3.30 | $2.76 | $0.5405 | 1,077,345.0 | +7.10% |
| 2025-05 | $3.14 | $2.60 | $0.54 | 589,443.0 | +6.25% |
| 2025-04 | $2.61 | $1.75 | $0.86 | 462,543.0 | +14.47% |
| 2025-03 | $2.97 | $2.07 | $0.90 | 592,174.0 | -24.75% |
| 2025-02 | $3.71 | $2.79 | $0.915 | 2,332,046.0 | -8.18% |
| 2025-01 | $4.68 | $2.95 | $1.73 | 1,702,122.0 | -11.76% |
Grace Therapeutics Inc-Aktien (GRCE) Preisverlauf 2024
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2024-12 | $4.96 | $3.22 | $1.74 | 1,611,698.0 | +14.58% |
| 2024-11 | $3.49 | $2.88 | $0.61 | 546,657.0 | +5.00% |
| 2024-10 | $3.32 | $3.10 | $0.22 | 79,104.0 | +0.00% |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):